Physician profile
Albert P Serrano
NPI 1366783060
$2,399.20
in general payments reported to CMS, 2019-2025
6 companies · $379 in 2025
The $379 reported for 2025 was more than what 75% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.07 · 2020: $129 · 2023: $141 · 2024: $1,650 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,170.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightforce Orthodontics, INC. | $1,523.85 | 2024-2025 | |
| Align Technology, INC. | $597.09 | 2023-2025 | Invisalign, Invisalign Touch Up, Invisalign First - Comprehensive Phase 2 |
| 3m Company | $201.28 | 2019-2020 | |
| Ormco Corporation | $45.47 | 2019-2023 | Spark |
| Nobel Biocare USA | $18.40 | 2023 | Nobelactive |
| Envista Holdings Corporation | $13.11 | 2024 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$250,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Serrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.